Debt-to-equity of ANI PHARMACEUTICALS INC from 30 Jun 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ANI PHARMACEUTICALS INC quarterly Debt-to-equity in % history and change rate from 30 Jun 2012 to 30 Sep 2025.
  • ANI PHARMACEUTICALS INC Debt-to-equity for the quarter ending 30 Sep 2025 was 198%, a 58% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

ANI PHARMACEUTICALS INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 198% +73% +58% 30 Sep 2025
Q2 2025 207% +107% +108% 30 Jun 2025
Q1 2025 178% +77% +76% 31 Mar 2025
Q4 2024 151% +42% +38% 31 Dec 2024
Q3 2024 125% +8.6% +7.4% 30 Sep 2024
Q2 2024 99% -25% -20% 30 Jun 2024
Q1 2024 101% -32% -24% 31 Mar 2024
Q4 2023 109% -21% -16% 31 Dec 2023
Q3 2023 116% -11% -8.6% 30 Sep 2023
Q2 2023 124% -5.8% -4.5% 30 Jun 2023
Q1 2023 133% +0.1% +0.08% 31 Mar 2023
Q4 2022 130% -4.6% -3.4% 31 Dec 2022
Q3 2022 127% -12% -8.8% 30 Sep 2022
Q2 2022 130% -7.6% -5.5% 30 Jun 2022
Q1 2022 133% -3% -2.2% 31 Mar 2022
Q4 2021 135% -4.2% -3% 31 Dec 2021
Q3 2021 140% +6.4% +4.8% 30 Sep 2021
Q2 2021 138% +10% +7.9% 30 Jun 2021
Q1 2021 136% +15% +12% 31 Mar 2021
Q4 2020 139% +24% +20% 31 Dec 2020
Q3 2020 133% +17% +15% 30 Sep 2020
Q2 2020 127% +7.7% +6.4% 30 Jun 2020
Q1 2020 121% -2.4% -2% 31 Mar 2020
Q4 2019 115% -12% -9.1% 31 Dec 2019
Q3 2019 116% -15% -12% 30 Sep 2019
Q2 2019 120% -5.2% -4.2% 30 Jun 2019
Q1 2019 123% +4.6% +3.9% 31 Mar 2019
Q4 2018 127% +15% +13% 31 Dec 2018
Q3 2018 131% +30% +30% 30 Sep 2018
Q2 2018 125% +27% +28% 30 Jun 2018
Q1 2018 119% +25% +26% 31 Mar 2018
Q4 2017 112% +25% +28% 31 Dec 2017
Q3 2017 101% +17% +20% 30 Sep 2017
Q2 2017 98% +15% +18% 30 Jun 2017
Q1 2017 94% +13% +16% 31 Mar 2017
Q4 2016 87% +6.4% +7.9% 31 Dec 2016
Q3 2016 84% +1.6% +1.9% 30 Sep 2016
Q2 2016 83% 30 Jun 2016
Q1 2016 81% 31 Mar 2016
Q4 2015 81% 31 Dec 2015
Q3 2015 83% 30 Sep 2015
Q1 2013 101% 31 Mar 2013
Q4 2012 93% 31 Dec 2012
Q3 2012 102% 30 Sep 2012
Q2 2012 112% 30 Jun 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.